GENE ONLINE|News &
Opinion
Blog

Rajaneesh K. Gopinath

WRITTEN BY Rajaneesh K. Gopinath

Jazz Pharma’s Xywav Becomes First FDA Approved Drug for a Rare Neurologic Disease
2021-08-13
The Defining Role of Metabolism in Human Health and Disease
2021-08-12
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
With Increasing Appeal for RNA Technology, Medford Startup Jumps on the SPAC Wagon to Go Public
2021-08-10
Roche Aspires for Dominance in DLBCL Market, Unveils Pivotal Trial Data for Polivy
2021-08-09
China’s Berry Oncology Secures $99.15 Million in Series B1, Sets Industry Record for Highest Overall Capital Raised
2021-08-06
Bayer Spends $2 Billion to Acquire a Startup on the Brink of an IPO
2021-08-05
Japan’s SoftBank Buys $5 billion Stake in Roche, Becoming One of its Largest Investors
2021-08-05
PacBio Bolsters its Long-Read Sequencing Workflow, Makes Second Acquisition in Two Weeks
2021-08-03
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
PerkinElmer Makes its Biggest Buy Yet Forking Out $5.25 Billion for Latest Acquisition
2021-07-30
Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
2021-07-26
PacBio Looks to Capture Short-Read Genome Sequencing Market with Omniome Acquisition
2021-07-20
Celgene Spinoff Arrives Wall Street with a $138 Million SPAC Deal
2021-07-19
FDA Approves Foundation Medicine’s Liquid Biopsy Test as Companion Diagnostic for Novartis’ Tabrecta
2021-07-18
1 3 4 5 6 7 20
Scroll to Top